Although rare in pediatrics, ischemic priapism carries significant risk of erectile dysfunction if not treated promptly. We report a case of idiopathic ischemic priapism in a male aged 14 years, refractory to traditional therapies, including aspiration/irrigation, phenylephrine injection, and distal shunt. However, the priapism resolved after intracavernosal injections of tissue plasminogen activator (tPA) with preservation of normal erectile function. To our knowledge, this is the first reported case of intracavernosal tPA for treatment of pediatric priapism. tPA may be a useful management option for recalcitrant ischemic priapism in pediatric patients and may prevent devastating outcomes such as lifelong erectile dysfunction.
Acute Management of Prolonged, Recalcitrant Priapism in a Pediatric Patient
- Views Icon Views
- Share Icon Share
- Search Site
Rachael Sherrer, Mario Otto, Sushant Srinivasan, Krista Grinde, Walid A. Farhat; Acute Management of Prolonged, Recalcitrant Priapism in a Pediatric Patient. Pediatrics June 2022; 149 (6): e2021054941. 10.1542/peds.2021-054941
Download citation file: